Low-dose Intravenous Dexamethasone at Different Times as Adjunvants for Brachial Plexus Blocks
Study Details
Study Description
Brief Summary
Dexamethasone has been tested as an effective adjuvant to prolong the effect of local anesthetics for peripheral nerve blocks, both perineurally and intravenously. The purpose of this study is to investigate the effect of the addition of dexamethasone (5mg) at different time to a standard ropivacaine solution (0.5%) on analgesic duration of interscalene block.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 4 |
Detailed Description
Interscalene brachial plexus block (ISB) is regarded as the standard of care for anesthesia and analgesia for shoulder surgery by providing the superior analgesia and reducing opioid consumption. After several hours when the effects of single injection ISB wear off, the patients often suffer moderate to severe pain of the surgical insult and required strong opioid analgesia. Efforts to prolong ISB duration by adding adjuvants to local anesthetic (eg. clonidine, dexmedetomidine) have been studied with promising results. Dexamethasone, has been added to local anesthetic solutions for ISB and has demonstrated promise in preliminary studies. Perineural dexamethasone (8-10mg) in conjunction with local anesthetic prolongs the duration of ISB with an effect sizes ranging from 40% to 75% (absolute effect ~ 6 to 10 hours). Dexamethasone, however, is only approved for intramuscular or intravenous administration and therefore perineural use is currently off-label. Intravenous administration of dexamethasone was reported to have similar effects as perineural route indicating the possible mechanism for prolonging analgesic duration might be due to the systemic effects of dexamethasone. We hypothesized: should that is the reason, systemic administration of dexamethasone at different time may provide similar effects on the duration of peripheral nerve block. Dexamethasone is a slow effect cortisone with long half-time, it is widely used at the beginning of surgery to prevent postoperative nausea and vomiting. A trial that demonstrates enhanced block quality and duration associated with intravenous dexamethasone at different time may allow us to achieve prolonged duration of effect if dexamethasone is used in perioperative period for different purpose. This would further identify the possible mechanism of dexamethasone to prolong the analgesia effect of local anesthetics.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: preoperative group Intravenous dexamethasone (5mg) is used when ultrasound guided ISB is performed. |
Drug: dexamethasone
Intravenous administration of dexamethasone at different time for the duration of ISB with 0.5% ropivacaine
Other Names:
|
| Active Comparator: postoperative group Ultasound guided ISB is performed before operation and intravenous dexamethasone (5mg) is used in postoperative care unit ( PACU) |
Drug: dexamethasone
Intravenous administration of dexamethasone at different time for the duration of ISB with 0.5% ropivacaine
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Duration of sensory block [one day postoperative]
from completion of ISB to VAS for pain > 0 ( in hours)
Secondary Outcome Measures
- Time to First Opioid Consumption [one day postoperative]
Time from completion of block procedure to first consumption of opioid analgesic (in hours)
- Opioid Consumption [two days postoperative]
Opioid consumption (in oral morphine equivalents) will be recorded at 12 hours, 24 hours and 48 hours
- Visual Analog Scale for pain ( from 0 to 10 ) [7 days postoperative]
Recorded at 12 hours, 24 hours, and 7 days 0 is no pain, 10 is the worst pain imaginable. Lower number is better.
- Postoperative Serum Blood Glucose [one day postoperative]
Measured on the morning of first day after surgery
- Infection [7 days postoperative]
Number of participants with localized infection at nerve block site
- Number of Participants With Postoperative Nausea and/or Vomiting [7 days postoperative]
Number of participants with postoperative nausea and/or vomiting assessed at 12 hours, 24, hours, and 7 days postoperatively
- Number of Participants With Nerve Damage From Interscalene Block [7 days postoperative]
Persistent paresthesia, and sensory/motor block at 7 days
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients undergoing arthroscopic shoulder surgery at Shanghai Sixth People's Hospital.
-
ASA functional status class I to II
-
Age 18 to 70 years
-
BMI ≤ 35 kg/m2
Exclusion Criteria:
-
Lack of patient consent
-
Allergy to dexamethasone or ropivacaine
-
BMI > 35 kg/m2
-
Contraindications to low dose dexamethasone including peptic ulcer disease, systemic infection, glaucoma, active varicella/herpetic infections, diabetes mellitus
-
Contraindications to ISB including severe Chronic Obstructive Pulmonary Disease (Forced expiratory volume < 40% predicted), coagulopathy, pre-existing neurologic deficit in ipsilateral upper extremity, localized infection
-
Pregnant or nursing females
-
Chronic opioid use defined as > 30mg oral morphine or equivalent per day
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Shanghai Jiaotong University affiliated Shanghai Sixth People's Hospital | Shanghai | China |
Sponsors and Collaborators
- Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Investigators
- Principal Investigator: Quanhong Zhou, MD., Ph.D, Shanghai Jiaotong University affiliated Shanghai Sixth People's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020-186